01—Abstract
Summary
Summary of the 10-K filed February 15, 2022. Cited figures are marked; the original filing is the authoritative source.
UnitedHealth Group Inc. (UNH) reported strong financial performance for the fiscal year ending December 31, 2021.
The company demonstrated robust revenue growth, increasing by 12%a year-over-year, driven by expansion in both its UnitedHealthcare and Optum segments. UnitedHealthcare saw a 11% revenue increase, largely due to growth in Medicare Advantage, Medicaid, and commercial offerings, serving approximately 2.1 million more people domestically. The Optum segment exhibited even stronger growth with a 14% revenue increase, particularly fueled by Optum Health's 36% revenue surge from value-based care and acquisitions, alongside solid performance in Optum Insight and Optum Rx.
Net earnings attributable to common shareholders grew by 12% to $17.3 billionb, or $18.08 per diluted share. The company's return on equity remained strong at 25.2%. UnitedHealth Group also generated substantial cash flow from operations, amounting to $22.3 billion, which supported significant investments in acquisitions, share repurchases, and dividend payments.
The company returned $10.3 billionc to shareholders through dividends and share repurchases, underscoring its commitment to shareholder value. The report also highlights the company's ongoing investments in technology and care delivery models, positioning it for continued growth in the evolving healthcare landscape.
02—Key points
Key Highlights
- Total revenues increased by 12% to $287.6 billion, driven by growth across both UnitedHealthcare and Optum segments.
- Net earnings attributable to common shareholders increased by 12% to $17.3 billion, with diluted earnings per share rising to $18.08.
- UnitedHealthcare served approximately 2.1 million more people domestically, with Medicare Advantage and Medicaid programs showing significant enrollment growth.
- Optum segment revenues grew by 14%, with Optum Health showing a substantial 36% increase, indicating strong performance in care delivery and value-based care.
- Cash flows from operations were robust at $22.3 billion, providing ample resources for acquisitions, share repurchases, and dividend payments.
- The company returned $10.3 billion to shareholders through dividends ($5.3 billion) and share repurchases ($5.0 billion).
- Return on equity remained strong at 25.2%, reflecting efficient capital utilization.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2021, UnitedHealth Group Inc kept $0.06.
- Revenue$287.60B100.0%
- Cost of revenue−$31.03B10.8%
- Gross profit$256.56B89.2%
- Operating costs−$232.59B80.9%
- Operating income$23.97B8.3%
- Interest, other & tax−$6.68B2.3%
- Net income$17.29B6.0%
Where FY2021 revenue went
$287.60B- Other operating costs: $190.01B, 66% of revenue
- SG&A: $42.58B, 15% of revenue
- Net income: $17.29B, 6.0% of revenue
- Cost of revenue: $31.03B, 11% of revenue
- Interest, other & tax: $6.68B, 2.3% of revenue
Kept 6.0% as net income
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2021filed February 15, 2022Financial Statements
FY2021 against FY2020
| Line item | FY2021FY2020 | Change |
|---|---|---|
| Revenue | $287.60B$257.14B | +11.8% |
| Cost of Revenue | $31.03B$30.75B | +0.9% |
| Gross Profit | $256.56B$226.40B | +13.3% |
| SG&A Expenses | $42.58B$41.70B | +2.1% |
| Operating Expenses | $263.63B$234.74B | +12.3% |
| Operating Income | $23.97B$22.41B | +7.0% |
| Interest Expense | $1.66B$1.66B | −0.2% |
| Net Income | $17.29B$15.40B | +12.2% |
| EPS (Basic) | $18.33$16.23 | +12.9% |
| EPS (Diluted) | $18.08$16.03 | +12.8% |
| Shares Outstanding (Basic) | 943.00M949.00M | −0.6% |
| Shares Outstanding (Diluted) | 956.00M961.00M | −0.5% |
05—Questions
Frequently Asked Questions
What were the main drivers of UnitedHealth Group's revenue growth in 2021?
Revenue growth was primarily driven by an increase in the number of individuals served across its UnitedHealthcare and Optum segments. This included growth in Medicare Advantage, Medicaid, and commercial offerings, as well as organic and acquisition growth within the Optum businesses, particularly in care delivery and health financial services.
How did the COVID-19 pandemic impact UnitedHealth Group's financial results?
The COVID-19 pandemic had a mixed impact. While it led to increased COVID-19 related care and testing costs, and negatively affected certain Optum services due to reduced clinical activity, it was partially offset by the temporary deferral of care by consumers. The company anticipates that deferred care may lead to higher future utilization.
What is the company's approach to shareholder returns, such as dividends and share repurchases?
UnitedHealth Group demonstrated a strong commitment to shareholder returns by increasing its quarterly dividend to an annual rate of $5.80 per share and repurchasing approximately $5.0 billion of its common stock during 2021. In total, the company returned $10.3 billion to shareholders.
Can you elaborate on the performance of the Optum segment?
The Optum segment delivered impressive growth, with revenues increasing by 14%. Optum Health saw a significant 36% revenue increase due to organic growth in value-based arrangements and acquisitions in care delivery. Optum Insight and Optum Rx also contributed positively with revenue increases of 13% and 4%, respectively, driven by growth in technology, services, and script volumes.
06—Continue